ABOUT LINDEN LAKE VENTURE CAPITAL

The Linden Lake team invests in next generation of biotechnology companies bringing transformative new molecular medicines to patients who are in desperate need; and has a unique combination of experience, access, speed, and motivation to execute on this goal.

Experience: The Linden Lake team has a deep skill set that combines biotechnology and medical expertise, IP/legal acumen, and private equity investment experience; as well as first-hand entrepreneurial success including in founding, building and selling biotech startup companies. Throughout our careers, we have been at the forefront of the business and intellectual property aspects of molecular medicine.

Access: Over the past 20 years our team has developed deep contacts with leading professors and technology transfer professionals at some of North America’s most elite research universities; as well as with senior executives at some of the world’s top biopharmaceutical companies and venture capital firms.

Motivation: We have dedicated our entire careers to biotechnology drug discovery, development, commercialization. As such, have seen firsthand the technical progress and the evolution of biopharmaceutical research, regulatory and business paradigms related to the treatment of cancer and rare diseases. We have also helplessly witnessed the fates of many with such diseases including close friends and family members.

Therefore, by building and investing in companies creating the next generation of molecular medicines, we aim to facilitate development of new treatments for millions of patients that currently have no hope of treatment – and push the current limits of drug discovery in more common disease contexts.